
    
      A Phase I, Open label, Randomized, Single center, 2 way Crossover Bioequivalence Study
      Comparing D961S (a Fixed-dose Combination Capsule of Esomeprazole 20 mg and Acetylsalicylic
      Acid 81 mg) with a Free Combination of Esomeprazole Capsule 20 mg + Buffered Acetylsalicylic
      Acid Tablet 81 mg After Repeated Oral Administration in Japanese Healthy Male Subjects
    
  